Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Fluorescence Lens Cell

By Drug Discovery Trends Editor | February 25, 2009

MicrocellStarna Scientific Development department has designed and patented a new ultra-micro volume fluorescence lens cell to perform UV/Visible spectrofluorometer analysis on smaller volume samples of typically five microlitres or less.

The ultra-micro cell provides a practical solution for customers where samples cannot be prepared in or diluted to larger volumes. 

Starna’s Type 19FL ultra-micro cell, which avoids the need for dilution, thereby minimizing reagents costs, is well suited to providing analysis in volumes typically handled in molecular biology and forensics applications. 

By offering high sensitivity, even in very small volumes, the Type 19FL ultra-micro cell is also suited to proteomics applications, where the sensitivity of the cell is sufficiently high to measure native fluorescence of proteins prepared in microlitre quantities. The cell design also allows the majority of the sample to be recovered.

The type 19FL ultra-micro lens cell is designed to enable ultra low volume fluorescence measurements in the 5 ul sample volume range. 

The cell allows good quality fluorescence measurements to be achieved using a conventional spectrofluorometer at sample volumes.

Using Far UV non-fluorescence quartz, the Type 19FL Ultra-micro volume fluorescence lens cell, 5 mm path length, can be supplied with a ‘Z’ height of 8.5, 15, and 20mm, and has been designed to make loading and flushing simple, with minimum dead volume. 

www.starna.com


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE